Notice: This company has been marked as potentially delisted and may not be actively trading. Sinovac Biotech (SVA) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Sinovac Biotech, Ltd. (SVA) stock forecast and price targetFebruary 12, 2025 | finance.yahoo.comSINOVAC: Outgoing Board Members Committed To Ensuring Smooth Transition With New Board MembersJanuary 16, 2025 | markets.businessinsider.comSINOVAC Initiated a Phase III Clinical Trial on Bivalent Vaccine Against Hand Foot and Mouth Disease (HFMD)December 16, 2024 | businesswire.comIndia extends export curbs on deoiled rice bran until end-JanAugust 16, 2024 | uk.finance.yahoo.comSinovac Biotech, Ltd.April 30, 2024 | money.usnews.comSINOVAC Reports Unaudited Second Half of 2023 Financial Results and Files 2023 Annual Report on Form 20-FApril 29, 2024 | finance.yahoo.comSINOVAC Reports Unaudited Second Half of 2023 Financial Results and Files 2023 Annual Report on Form 20-FApril 29, 2024 | businesswire.comSinovac Amends Shareholder Rights PlanFebruary 21, 2024 | businesswire.comSinovac Amends Shareholder Rights PlanFebruary 21, 2024 | businesswire.comSinovac Board Rejects Partial Tender Offer By Alternative Liquidity Index - Quick FactsJanuary 18, 2024 | markets.businessinsider.comNepal to destroy 4 million doses of China’s Sinovac shots as China refuses to take back vaccinesJanuary 3, 2024 | msn.comSinovac Biotech Ltd SVADecember 9, 2023 | morningstar.comPneumonia outbreak in China is no reason for alarm: WHONovember 24, 2023 | msn.comSINOVAC Reports on the Clinical Trial Progress of its Anti-COVID-19 Antibody SA55 InjectionSeptember 11, 2023 | finance.yahoo.comSinovac Board of Directors Unanimously Rejects an Unsolicited Partial Tender OfferSeptember 5, 2023 | businesswire.comSinovac Confirms Receipt of an Unsolicited Partial Tender OfferAugust 29, 2023 | finance.yahoo.comSinovac Announces Change of Legal Representative of Sinovac BeijingAugust 28, 2023 | finance.yahoo.comSINOVAC Reports Unaudited First Half of 2023 Financial ResultsAugust 15, 2023 | finance.yahoo.comSVA - Sinovac Biotech Ltd.July 20, 2023 | uk.finance.yahoo.comSINOVAC’s CoronaVac® Answers Hong Kong’s Need for Self-Pay COVID-19 VaccinesMay 10, 2023 | finance.yahoo.comSINOVAC Reports Unaudited Second Half of 2022 Financial Results and Files 2022 Annual Report on Form 20-FMay 1, 2023 | finance.yahoo.comSinovac Biotech Stock Soars (SVA)March 2, 2023 | thestreet.comSINOVAC Reports Unaudited First Half of 2022 Financial ResultsDecember 29, 2022 | finance.yahoo.comWHO chief hopeful COVID emergency will end next yearDecember 15, 2022 | msn.comSINOVAC Biotech Receives WHO Prequalification For Varicella VaccineNovember 4, 2022 | markets.businessinsider.comSINOVAC Varicella Vaccine Prequalified by WHONovember 4, 2022 | finance.yahoo.comSINOVAC to Showcase Products at CPHI FrankfurtOctober 28, 2022 | finance.yahoo.comROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Sinovac Biotech Ltd. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action Against 1Globe Capital LLC and Certain of its Officers - SVAOctober 1, 2022 | prnewswire.comSinovac Biotech Ltd. (SVA)September 23, 2022 | finance.yahoo.comSINOVAC Approved to Initiate Clinical Trial for Its Omicron Containing COVID-19 Vaccine in ChileSeptember 6, 2022 | finance.yahoo.com1Globe Capital Deadline AlertAugust 20, 2022 | stockhouse.comSinovac Biotech LtdAugust 18, 2022 | reuters.comSINOVAC COVID-19 Vaccine Approved for Use in Children Above 6 months of Age in Hong KongAugust 3, 2022 | finance.yahoo.comSINOVAC Initiates Clinical Trial for Its Quadrivalent Influenza Vaccine in ChileJuly 19, 2022 | finance.yahoo.comSinovac: Anvisa Approves CoronaVac For Emergency Use In Children Aged 3-5 YearsJuly 14, 2022 | nasdaq.comSINOVAC COVID-19 Vaccine Is Authorized for Emergency Use in Kids Aged 3-5 In BrazilJuly 14, 2022 | finance.yahoo.comSinovac Biotech COVID-19 vaccine conditionally registered in South AfricaJune 27, 2022 | seekingalpha.comChina's Sinovac COVID-19 Vaccine CoronaVac Registered For Use In South AfricaJune 25, 2022 | nasdaq.comSinovac's COVID-19 vaccine conditionally registered in South AfricaJune 25, 2022 | reuters.comSINOVAC COVID-19 Vaccine Is Conditionally Registered In South AfricaJune 25, 2022 | finance.yahoo.comSINOVAC Polio Vaccine Prequalified by WHOJune 8, 2022 | finance.yahoo.comSinovac Biotech (NASDAQ:SVA), Short Interest ReportJune 1, 2022 | benzinga.comSINOVAC Updates the Status Under Holding Foreign Companies Accountable ActMay 6, 2022 | finance.yahoo.comSinovac Biotech GAAP EPS of $74.27, revenue of $19.4BMay 2, 2022 | seekingalpha.comSINOVAC Reports Unaudited Second Half of 2021 Financial Results and Files 2021 Annual Report on Form 20-FApril 29, 2022 | stockhouse.comSinovac COVID vaccine 38% effective in young kids —Chilean studyMarch 26, 2022 | msn.comSinovac booster shows 98% protection against death/severe COVID in people over 60 in studyMarch 24, 2022 | seekingalpha.comSinovac COVID vaccine 38% effective in young kids - Chilean studyMarch 16, 2022 | reuters.comSINOVAC assinou carta de acordo com o Ministério da Saúde Pública do Equador para construir uma fábrica de vacinasFebruary 27, 2022 | prnewswire.comSINOVAC firmó la carta de acuerdo con el Ministerio de Salud Pública de Ecuador para construir planta de fabricación de vacunasFebruary 26, 2022 | prnewswire.com Get Sinovac Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for SVA and its competitors with MarketBeat's FREE daily newsletter. Email Address SVA Media Mentions By Week SVA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SVA News Sentiment▼0.000.60▲Average Medical News Sentiment SVA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SVA Articles This Week▼00▲SVA Articles Average Week Get Sinovac Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for SVA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ARWR News HCM News EWTX News MIRM News AMRX News GMTX News PTGX News LGND News CNTA News BHC News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SVA) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sinovac Biotech Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sinovac Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
